Cloverfields Capital Group, LP Zoetis Inc. Transaction History
Cloverfields Capital Group, LP
- $285 Million
- Q3 2025
A detailed history of Cloverfields Capital Group, LP transactions in Zoetis Inc. stock. As of the latest transaction made, Cloverfields Capital Group, LP holds 22,880 shares of ZTS stock, worth $2.72 Million. This represents 1.18% of its overall portfolio holdings.
Number of Shares
22,880
Previous 23,012
0.57%
Holding current value
$2.72 Million
Previous $3.59 Million
6.72%
% of portfolio
1.18%
Previous 1.21%
Shares
2 transactions
Others Institutions Holding ZTS
# of Institutions
2,082Shares Held
423MCall Options Held
1.82MPut Options Held
1.94M-
Vanguard Group Inc Valley Forge, PA42.3MShares$5.03 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$4.38 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.6MShares$2.33 Billion0.1% of portfolio
-
Morgan Stanley New York, NY16.9MShares$2.01 Billion0.16% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL15.9MShares$1.89 Billion1.96% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $55.6B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...